Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:TKPYY
- CUSIP: N/A
- Web: www.takeda.com
- Market Cap: $40.91737 billion
- Outstanding Shares: 1,560,000,000
- 50 Day Moving Avg: $25.37
- 200 Day Moving Avg: $23.18
- 52 Week Range: $19.96 - $26.35
Sales & Book Value:
- Trailing P/E Ratio: 39.10
- P/E Growth: 0.00
- Annual Revenue: $15.61 billion
- Price / Sales: 2.58
- Book Value: $10.94 per share
- Price / Book: 2.36
- EBIDTA: $4.71 billion
- Net Margins: 7.86%
- Return on Equity: 9.76%
- Return on Assets: 4.88%
- Debt-to-Equity Ratio: 0.36%
- Current Ratio: 1.73%
- Quick Ratio: 1.50%
- Average Volume: 39,661 shs.
- Beta: 0.46
Frequently Asked Questions for Takeda Pharmaceutical (OTCMKTS:TKPYY)
What is Takeda Pharmaceutical's stock symbol?
Takeda Pharmaceutical trades on the OTCMKTS under the ticker symbol "TKPYY."
Who are some of Takeda Pharmaceutical's key competitors?
Some companies that are related to Takeda Pharmaceutical include Thermo Fisher Scientific (TMO), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Stryker Corporation (SYK), Shire PLC (SHPG), Aetna (AET), Anthem (ANTM), Fresenius SE (FSNUY), Becton, Dickinson and Company (BDX), Express Scripts Holding Company (ESRX), Boston Scientific Corporation (BSX), McKesson Corporation (MCK), Intuitive Surgical (ISRG), Humana (HUM), Baxter International (BAX), Vertex Pharmaceuticals Incorporated (VRTX), Teva Pharmaceutical Industries Limited (TEVA) and HCA Holdings (HCA).
Who are Takeda Pharmaceutical's key executives?
Takeda Pharmaceutical's management team includes the folowing people:
- Yasuchika Hasegawa, Chairman of the Board
- Christophe Weber, President, Chief Executive Officer, Representative Director
- Shinji Honda, President of Subsidiary, Corporate Strategy Office, Director
- Andrew S. Plump, Chief Medical & Scientific Officer, Director
- Masato Iwasaki, President of Japan Pharma Business Unit, Director
- Yasuhiko Yamanaka, Director
- Emiko Azuma, Independent Director
- Jean-Luc Butel, Independent Director
- Yoshiaki Fujimori, Independent Director
- Koji Hatsukawa, Independent Director
How do I buy Takeda Pharmaceutical stock?
Shares of Takeda Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Takeda Pharmaceutical's stock price today?
MarketBeat Community Rating for Takeda Pharmaceutical (OTCMKTS TKPYY)MarketBeat's community ratings are surveys of what our community members think about Takeda Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Takeda Pharmaceutical stock can currently be purchased for approximately $25.77.
Consensus Ratings for Takeda Pharmaceutical (OTCMKTS:TKPYY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Takeda Pharmaceutical (OTCMKTS:TKPYY)
(Data available from 6/27/2015 forward)
|1/31/2017||Canaccord Genuity||Reiterated Rating||Buy|
Earnings History for Takeda Pharmaceutical (OTCMKTS:TKPYY)Earnings History by Quarter for Takeda Pharmaceutical (OTCMKTS TKPYY)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Takeda Pharmaceutical (OTCMKTS:TKPYY)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Takeda Pharmaceutical (OTCMKTS:TKPYY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Takeda Pharmaceutical (OTCMKTS:TKPYY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Takeda Pharmaceutical (OTCMKTS:TKPYY)
Latest Headlines for Takeda Pharmaceutical (OTCMKTS:TKPYY)
Takeda Pharmaceutical (TKPYY) Chart for Tuesday, June, 27, 2017